A194 A POSSIBLE ASSOCIATION BETWEEN SECUKINUMAB AND NEW-ONSET INFLAMMATORY BOWEL DISEASE: A CASE SERIES

BACKGROUND: Secukinumab is a monoclonal antibody targeting interleukin-17A and is commonly used for managing autoimmune diseases such as, psoriasis, psoriatic arthritis, and ankylosing spondylitis. Prior studies have suggested that anti-IL17 therapy may worsen symptoms in patients with pre-existing...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Can Assoc Gastroenterol
Glavni autori: Sarker, A, Shukla, T, Rostom, A, Sim, J, McCurdy, J D
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2021
Teme:
Poster of Distinction
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958707/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwab002.192
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items